Related Experiment Videos

In vitro susceptibility of Haemophilus somnus to 33 antimicrobial agents

Insights

Minimal inhibitory concentrations for Haemophilus somnus were determined. Strains showed high susceptibility to penicillin G, ampicillin, colistin, and novobiocin, but not spiramicin or sulfadimethoxine.

Area of Science:

  • Veterinary Microbiology
  • Antimicrobial Resistance
  • Bacterial Pathogenesis

Background:

  • Haemophilus somnus is a significant pathogen in livestock, causing various diseases.
  • Understanding antimicrobial susceptibility is crucial for effective treatment and disease management.
  • Limited data exists on the comprehensive antimicrobial profiles of H. somnus isolates.

Purpose of the Study:

  • To determine the minimal inhibitory concentrations (MICs) of 33 antimicrobial agents against Haemophilus somnus.
  • To identify antimicrobial agents effective against H. somnus.
  • To assess the prevalence of resistance to specific antimicrobials in H. somnus strains.

Main Methods:

  • Agar dilution method was employed to test 33 antimicrobial agents.
  • Multiple strains of Haemophilus somnus were utilized in the study.
  • MIC values were systematically recorded for each antimicrobial agent.

Main Results:

  • Haemophilus somnus strains exhibited high susceptibility to penicillin G, ampicillin, colistin, and novobiocin.
  • In contrast, strains were not susceptible to spiramicin and sulfadimethoxine.
  • The study identified streptomycin-resistant strains of H. somnus.

Conclusions:

  • Penicillin G, ampicillin, colistin, and novobiocin are potential therapeutic options for H. somnus infections.
  • Spiramicin and sulfadimethoxine are unlikely to be effective treatments for H. somnus.
  • The emergence of streptomycin resistance in H. somnus necessitates careful antimicrobial selection.

Related Concept Videos